Concepedia

A phase II study of high dose epirubicin in unresectable non small cell lung cancer

HH Berendsen, D. A. Piers, J. Smeets, A. Riva, PE Postmus

British Journal of Cancer · 1992 · 30 citations · 18 references

Open access

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyPharmacokinetics Of Anticancer AgentsLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsPharmacokinetics Of Anticancer DrugsAnthracycline-based ChemotherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Ii InvestigationStudy Phase

References

18

Dose: A critical factor in cancer chemotherapy

Emil Frei, George P. Canellos · The American Journal of Medicine · 1980 · 848 citations

Medicine, Oncology, Pharmacology +14

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

E Rapp, Joseph L. Pater, Andrew R. Willan et al. · Journal of Clinical Oncology · 1988 · 700 citations

Medicine, Oncology, Chemotherapy +16

Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.

Frank M. Torti, Michael M. Bristow, Stephen K. Carter et al. · PubMed · 1986 · 199 citations

Medicine, Cardiology, Pharmacology +14

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

RL Woods, CJ Williams, John A. Levi et al. · British Journal of Cancer · 1990 · 158 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

A new international staging system for lung cancer

C. F. Mountain · CHEST Journal · 1986 · 127 citations

Medicine, Oncology, Surgery +14